John S. Cooperwood to Humans
This is a "connection" page, showing publications John S. Cooperwood has written about Humans.
Connection Strength
0.100
-
Musa MA, Joseph MY, Latinwo LM, Badisa V, Cooperwood JS. In vitro evaluation of 3-arylcoumarin derivatives in A549 cell line. Anticancer Res. 2015 Feb; 35(2):653-9.
Score: 0.025
-
Wan Z, Musa MA, Joseph P, Cooperwood JS. Synthesis and biological activity of 3-N-substituted estrogen derivatives as breast cancer agents. Mini Rev Med Chem. 2013 Jul; 13(9):1381-8.
Score: 0.023
-
Musa MA, Khan MO, Cooperwood JS. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs). Curr Med Chem. 2007; 14(11):1249-61.
Score: 0.014
-
Cooperwood JS, Boyd V, Gumina G, Chu CK. Synthesis of L-3'-hydroxymethylribonucleosides. Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb; 19(1-2):219-36.
Score: 0.009
-
Green JE, Cooperwood JS, Taka E, Soliman KF, Goodman CB, Reams RR. Comparative proteomic analysis reveals growth inhibition by 3-N-alkyloxyestradiol derivative (SERM) in prostate cancer cells. Cancer Genomics Proteomics. 2014 Jul-Aug; 11(4):195-200.
Score: 0.006
-
Musa MA, Badisa VL, Latinwo LM, Cooperwood J, Sinclair A, Abdullah A. Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines. Anticancer Res. 2011 Jun; 31(6):2017-22.
Score: 0.005
-
Musa MA, Cooperwood JS, Khan MO, Rahman T. In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs. Arch Pharm (Weinheim). 2011 Feb; 344(2):102-10.
Score: 0.005
-
Badisa RB, Darling-Reed SF, Joseph P, Cooperwood JS, Latinwo LM, Goodman CB. Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells. Anticancer Res. 2009 Aug; 29(8):2993-6.
Score: 0.004
-
Musa MA, Cooperwood JS, Khan MO. A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem. 2008; 15(26):2664-79.
Score: 0.004
-
Kong L, Cooperwood JS, Huang SH, Chu CK, Boudinot FD. Pharmacokinetic evaluation of 3'-azido-2', 3'-dideoxyuridine-5'-O-valinate-hydrochloride as a prodrug of the anti-HIV nucleoside 3'-azido-2', 3'-dideoxyuridine. Antivir Chem Chemother. 2003 Sep; 14(5):263-70.
Score: 0.003
-
Wang P, Hong JH, Cooperwood JS, Chu CK. Recent advances in L-nucleosides: chemistry and biology. Antiviral Res. 1998 Dec; 40(1-2):19-44.
Score: 0.002